AQR's $95M Flex series reveal a mandate-driven machine

Four Form Ds from AQR Capital Management reached SEC EDGAR on the same morning in late August, each one opening a new series under the firm's Flex 1 Series LLC umbrella and together reporting $95 million already sold — $15 million in Series A83, $50 million in Series A85, and $15 million each in Series F59 and F67. All four carry the same first-sale date, August 12, 2026, and all four are classified as hedge funds; because the total offering amount on each filing is undisclosed, the $95 million represents sales to date, not the ceiling.

The forms don't say what distinguishes one sleeve from another, and the names — A83, A85, F59, F67 — give no indication of strategy; the related persons on each filing, AQR Capital Management II LLC and AQR Capital Management LLC, identify who stands behind the umbrella but not why four series appeared the same day. Separate legal series, one filing batch, identical sale dates — that coordination is what the paperwork shows.

For allocators weighing liquid alts, the batch's shape matters more than the labels. Three sleeves sit at $15 million and one at $50 million, the pattern of a conduit taking mandate-sized checks rather than a single strategy marketed as one pool. The series structure keeps the pieces legally separate under one umbrella, and the identical dates suggest these four were booked together; whether that means one investor placing $95 million in slices or several investors moving in step, the filings don't say.

The $50 million sleeve is the number worth holding. Alone it is larger than the other three combined, and that gap gives the batch the look of an assembly job — same day, same chassis, different check sizes. The next Flex series filing will tell whether August 12 was a one-off or a rhythm.